rolipram has been researched along with Dermatitis, Atopic in 2 studies
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akama, T | 1 |
| Baker, SJ | 1 |
| Zhang, YK | 1 |
| Hernandez, V | 1 |
| Zhou, H | 1 |
| Sanders, V | 1 |
| Freund, Y | 1 |
| Kimura, R | 1 |
| Maples, KR | 1 |
| Plattner, JJ | 1 |
| Purushothaman, B | 1 |
| Arumugam, P | 1 |
| Kulsi, G | 1 |
| Song, JM | 1 |
2 other studies available for rolipram and Dermatitis, Atopic
| Article | Year |
|---|---|
Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Boron Compounds; Bridged | 2009 |
Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis.
Topics: Animals; Catechols; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 4; Dermatitis | 2018 |